Tregoning Kathleen 4
4 · Spero Therapeutics, Inc. · Filed Nov 12, 2021
Insider Transaction Report
Form 4
Tregoning Kathleen
Director
Transactions
- Award
Stock Option (right to buy)
2021-11-11+15,000→ 15,000 totalExercise: $16.91Exp: 2031-11-11→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option will vest in thirty-six equal monthly installments at the end of each successive month following November 11, 2021, subject to the Reporting Person's continued service as a director through the applicable vesting dates.